Join
Live feed
·
NEWSReleasevia Quantisnow
Vaccitech plc logo

Vaccitech Renames As Barinthus Biotherapeutics To Highlight Strategic Evolution Into A T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, And Cancer; To Trade Under New Name And Ticker 'BRNS' Effective Nov. 7

ByQuantisnow·Wall Street's wire, on your screen.
VACC· Vaccitech plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VACC (Vaccitech plc) and more on Quantisnow.